Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Gastroenterology

Treatment Strategy: What to Expect from Standard HE Care

At a Glance

The most effective standard treatment for hepatic encephalopathy (HE) is a combination of lactulose and rifaximin. These medications work together in the gut to lower ammonia levels in the blood, helping to clear confusion and prevent future hospitalizations.

When you or a loved one are hospitalized for an overt episode of Hepatic Encephalopathy (HE), the treatment can seem like a whirlwind of syrups, pills, and tests. Understanding what “good care” looks like according to clinical guidelines can help you advocate for yourself or your loved one.

Modern medical guidelines from major liver societies (like AASLD and EASL) recommend a four-pronged approach to managing an HE crisis [1]:

  1. Find and Fix the Trigger: Identifying and treating the “precipitating factor” (like an infection or dehydration) is the most critical first step [1].
  2. Gut-Based Therapy: Starting medications to flush toxins and ammonia out of the digestive tract [1].
  3. Nutritional Support: Providing adequate calories and protein to prevent muscle wasting, which actually makes HE worse [1].
  4. Long-Term Planning: Evaluating the need for advanced treatments, such as a liver transplant, if episodes become frequent [2][3].

The Gold Standard: Lactulose and Rifaximin

The primary goal of HE treatment is to lower the level of ammonia in the blood. Two medications form the “foundation” of this therapy.

1. Lactulose (The First Line)

Lactulose is a synthetic sugar syrup that works in the gut in two ways. First, it acts as a laxative to “flush” ammonia out of the colon. Second, it changes the acidity of the gut so that ammonia is trapped in the stool and cannot be absorbed back into the blood [4].

  • The Goal: Lactulose is not a “fixed dose” medication. It must be titrated (adjusted) until the patient is having exactly 2–3 soft bowel movements per day [1].

2. Rifaximin (The Critical Add-On)

Rifaximin is a specialized antibiotic that is “non-absorbable,” meaning it stays in the gut rather than entering the bloodstream [5]. It works by killing the specific bacteria that produce ammonia [6].

  • Why both? Research shows that while lactulose works well, adding rifaximin significantly reduces the risk of needing to go back to the hospital. Using both together is much more effective than using either one alone [7][8].

Additional Treatment Options

If the standard combination isn’t enough, doctors may use “add-on” therapies to further lower ammonia or support the brain.

  • L-ornithine L-aspartate (LOLA): This is often given as an IV during a hospital stay. It helps the body’s remaining healthy liver and muscle cells convert ammonia into harmless substances like urea, which can speed up recovery from a flare-up [9][10].
  • Branched-Chain Amino Acids (BCAA): These are specialized protein supplements. Unlike regular protein, which can increase ammonia, BCAAs provide energy to the muscles (which help clear ammonia) and are a safe second-line option for patients who are struggling with muscle loss [11][12].

What to Expect

Treatment for HE is often successful, and many patients wake up from their “fog” relatively quickly once triggers are addressed and medications are started. However, the most important part of treatment happens at home: consistency. Ensuring medications are taken exactly as prescribed to maintain those 2–3 bowel movements is the best way to keep the brain clear [13][14].

Common questions in this guide

What is the main goal of hepatic encephalopathy treatment?
The primary goal is to lower the level of ammonia in the blood. This is usually achieved by finding and fixing the underlying trigger and using gut-based medications to flush toxins out of the body.
Why do I need to take both lactulose and rifaximin for HE?
Research shows that using both medications together is much more effective than using either alone. Lactulose traps and flushes ammonia from the gut, while rifaximin kills the specific bacteria that produce ammonia in the first place.
How do I know if I am taking the right dose of lactulose?
Lactulose is not a fixed-dose medication. You must work with your doctor to adjust, or titrate, your dose until you are having exactly two to three soft bowel movements per day to effectively clear ammonia.
Can protein supplements help with hepatic encephalopathy?
Yes, specialized protein supplements called Branched-Chain Amino Acids (BCAAs) can help. Unlike some regular proteins that can increase ammonia, BCAAs provide energy to muscles to help clear ammonia and are safe for patients struggling with muscle loss.
When should we discuss a liver transplant for HE?
If overt hepatic encephalopathy episodes become frequent even when you are taking standard medications, it is recommended to begin evaluating the need for advanced treatments like a liver transplant.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I currently on the recommended 'gold standard' combination of both lactulose and rifaximin?
  2. 2.What is the specific plan for 'titrating' the lactulose dose—how much should I take to ensure 2–3 soft bowel movements a day?
  3. 3.What is the backup plan if the current medications aren't enough to prevent hospitalization?
  4. 4.Could adding BCAA (branched-chain amino acids) or LOLA help speed up recovery or prevent muscle loss?
  5. 5.Since there has been an overt HE episode, should we begin the conversation about a liver transplant evaluation?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Overt hepatic encephalopathy: management and prevention of recurrence.

    Sweeney E, Richardson P

    British journal of nursing (Mark Allen Publishing) 2020; (29(Sup17)):S14-S17 doi:10.12968/bjon.2020.29.Sup17.S14.

    PMID: 32976024
  2. 2

    Investigation of Post-Transplant Mental Well-Being in Liver Transplant Recipients with Hepatic Encephalopathy.

    Saritaş S, Tarlaci S, Bulbuloglu S, Guneş H

    Journal of clinical medicine 2024; (13(11)) doi:10.3390/jcm13113249.

    PMID: 38892960
  3. 3

    Radiological Intervention for Shunt Related Encephalopathy.

    Nardelli S, Gioia S, Ridola L, Riggio O

    Journal of clinical and experimental hepatology 2018; (8(4)):452-459 doi:10.1016/j.jceh.2018.04.008.

    PMID: 30564003
  4. 4

    Complications of Liver Disease.

    Lidbury JA

    The Veterinary clinics of North America. Small animal practice 2025; (55(4)):559-577 doi:10.1016/j.cvsm.2025.03.008.

    PMID: 40379581
  5. 5

    [Prevention and treatment of hepatic encephalopathy].

    Sivolap YP

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2017; (117(10)):144-147 doi:10.17116/jnevro2017117101144-147.

    PMID: 29171503
  6. 6

    Microbial Approaches to Treat and Prevent Hepatic Encephalopathy.

    Munk Lauridsen M, Jonasson E, Bajaj JS

    Gastroenterology clinics of North America 2025; (54(2)):429-451 doi:10.1016/j.gtc.2024.12.006.

    PMID: 40348497
  7. 7

    Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence.

    Hudson M, Schuchmann M

    European journal of gastroenterology & hepatology 2019; (31(4)):434-450 doi:10.1097/MEG.0000000000001311.

    PMID: 30444745
  8. 8

    Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy.

    Wang Z, Chu P, Wang W

    Drug design, development and therapy 2019; (13()):1-11 doi:10.2147/DDDT.S172324.

    PMID: 30587923
  9. 9

    L-ornithine L-aspartate in bouts of overt hepatic encephalopathy.

    Sidhu SS, Sharma BC, Goyal O, et al.

    Hepatology (Baltimore, Md.) 2018; (67(2)):700-710 doi:10.1002/hep.29410.

    PMID: 28749571
  10. 10

    Solving doubts about L-ornithine L-aspartate for overt hepatic encephalopathy: Whom and how to treat.

    Amodio P, Ampuero J

    Hepatology (Baltimore, Md.) 2018; (67(2)):476-478 doi:10.1002/hep.29530.

    PMID: 28921625
  11. 11

    Management of Refractory Hepatic Encephalopathy.

    Vongsavath T, Manne V, Sakae C, Saab S

    Digestive diseases and sciences 2026; (71(5)):1686-1693 doi:10.1007/s10620-025-09591-x.

    PMID: 41350964
  12. 12

    Systematic review with meta-analysis: Branched-chain amino acid supplementation in liver disease.

    van Dijk AM, Bruins Slot AS, Portincasa P, et al.

    European journal of clinical investigation 2023; (53(3)):e13909 doi:10.1111/eci.13909.

    PMID: 36394355
  13. 13

    Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all-cause admissions in patients on the liver transplant waiting list.

    Salehi S, Tranah TH, Lim S, et al.

    Alimentary pharmacology & therapeutics 2019; (50(4)):435-441 doi:10.1111/apt.15326.

    PMID: 31169941
  14. 14

    The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α.

    Orr JG, Currie CJ, Berni E, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2016; (36(9)):1295-303 doi:10.1111/liv.13111.

    PMID: 26950766

This page provides general information on standard hepatic encephalopathy treatments for educational purposes. Always consult your hepatologist or care team before adjusting lactulose doses or starting new medications.

Get notified when new evidence is published on Hepatic Encephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.